Sanofi launches its first digital accelerator driven by new talent and focused on growth

Sanofi-Aventis Group

Sanofi launches its first digital accelerator driven by new talent and focused on growth

Paris, June 8, 2022. Sanofi has announced the launch of its first digital accelerator, aimed at helping the company realize its ambition to be among the leaders in digital health. The goal of this accelerator is to develop products and solutions in support of Sanofi’s mission to transform drug practice through digital, data and artificial intelligence (AI). Located in Paris, it already relies on a team of more than 75 experts from around the world and will continue to recruit top talent, specialized Product managementDevelopment Full stack And Information science.

A place of diversity, the digital accelerator includes both internal mobility and external recruitment teams and is supported by its launch. Accelerator Academy Dedicated to improving staff skills. A partnership with an international non-profit organization Women in Tech It was also established to fill the void left by women in the digital sector. Digital Accelerator will have 300 employees in the most relevant geographic areas to support Sanofi’s global digital strategy, attract new talent and embed more agile work practices in the company’s culture.

The goal of this accelerator is to meet the insufficient needs of patients with atopic dermatitis primarily in France, Italy and Spain. His team is already working to develop an integrated platform and data tools to better engage healthcare professionals and educate them and their patients about the disease and available treatment options.

Sanofi, Executive Vice President and Chief Digital Officer
“Sanofi’s digital transformation is as much about technology as it is about cultural and business transformation. Digital Accelerators will help us democratize our data usage, develop agility at all levels of the organization, and accelerate innovation for patients and healthcare professionals – quickly and efficiently. This investment in digital accelerators once again illustrates our desire to transform our drug practice and provide better solutions to patients. A

Since launching its new global digital strategy in 2021, Sanofi has worked together to lay a solid foundation for digital tools and data, create commercial value, develop new skills and promote digital and data culture. Through the training of more than 16,000 employees. More than 300 new talents from France, Spain, the United States and Canada have joined Sanofi in the last 18 months to strengthen their expertise in digital, data and cyber security.

Ongoing digital transformation has already yielded significant results, in particular:

  • Accelerate the discovery of new targets through artificial intelligence;

  • Acceleration of image analysis in R&D for artificial intelligence (which is done in minutes compared to previous weeks);

  • Improve the efficiency of clinical trials through the use of real-life data to reduce patient enrollment and allow participants to transmit their data and digital biomarkers remotely;

  • Accelerate access to clinical reports for health authorities by providing data on cloud and natural language processing;

  • Strengthening exchanges with healthcare professionals Thanks to an integrated CRM and optimal channel solution, already established in 18 countries;

  • Optimize advertising and promotion costs across multiple markets and multiple products through data integration and artificial intelligence;

  • Digitizing manufacturing processes with modern solutions and improving supply chain performance with predictable AI.

By 2025, Sanofi’s state-of-the-art digital health platform will deliver new digital offers, empower patients and healthcare professionals with new digital experiences, drive innovation and generate revenue. Skills at all levels of the value chain – from research and development to manufacturing, to commercial activities. Deep integration of digital, technology and data solutions is essential to transform drug practice and bring better solutions to patients.

About Sanofi
We are an innovative, World Health Organization driven by a purpose: to follow the miracles of science to improve human life. Our teams, present in over a hundred countries, are working to transform the practice of medicine into the impossible. We provide therapeutic solutions that can change patients’ lives and vaccines that protect millions of people around the world driven by the ambition of sustainable development and our social responsibility.
Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY.

Media relations
Nicholas Obrist | +33 6 77 21 27 55 |
Kate Conway | + 1 508 364 4931 |
Victor Rowlett | + 33 6 70 93 71 40 |

Investor Relations
Eva Schaefer-Janssen | + 33 7 86 80 56 39 |
Arnaud Delapine | + 33 6 73 69 36 93 |
Quarantine draincourt | + 33 6 40 56 92 21 |
Felix Laser | +1 908 612 7239 |
Priya Nanduri | +1 617 764 6418 |
Nathali Pham | +33 7 85 93 30 17 |


Leave a Comment